Drug-eluting stent and drug-coated balloon for the treatment of de novo diffuse coronary artery disease lesions: A retrospective case series study.

ABSTRACT:

Background

The hybrid strategy of a combination of drug-eluting stent (DES) and drug-coated balloon (DCB) is promising for the treatment of de novo diffuse coronary artery disease (CAD).

Hypothesis

To investigate the efficacy and functional results of hybrid strategy.

Methods

This case series study included patients treated with a hybrid approach for de novo diffuse CAD between February 2017 and November 2021. Postprocedural quantitative flow ratio (QFR) was used to evaluate the functional results. The primary endpoint was procedural success rate. The secondary endpoints were major adverse cardiovascular events (MACE) including cardiac death, myocardial infarction (MI) (including peri-procedural MI), and target vessel revascularization.

Results

A total of 109 p

SUBMITTER: Xu H 

PROVIDER: S-EPMC10716315 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature